Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers

Ultrasound-Guided Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07815587

Acronym

ULPSYK

Enrollment

Registered

2026-09-11

Start date

2026-09-01

Completion date

2027-12-01

Last updated

2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intramuscular Injection, Psychotic Disorder, SCHIZOPHRENIA 1 (Disorder)

Brief summary

This observational study will use ultrasound to assess the gluteal musculature in patients receiving depot antipsychotic medication and in healthy volunteers. The study aims to improve knowledge about anatomical conditions relevant to intramuscular depot injections.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* adults receiving depot antipsychotic medication and able to provide informed consent. Healthy volunteers: adults able to provide informed consent.

Exclusion criteria

* Acute infections at the injection site * Previous surgery that makes ultrasound examination difficult

Design outcomes

Primary

Measure	Time frame	Description
Ultrasound-based assessment of gluteal anatomy, including measurements relevant to identifying an appropriate intramuscular injection site.	At the ultrasound examination (single study visit).	Primary outcome is skin muscle (gluteus) distanse in millimeter

Outcome results